Press Releases

23 March 2018

Cofactor Genomics Partners With the National Cancer Institute

Cofactor Genomics, the developer of advanced RNA analysis tools, has announced that it has entered into an agreement with the National Cancer Institute, to demonstrate the clinical utility of its immune-profiling assay, Cofactor Paragon.